Claus Wittekindt
Papers
1
Total Citations
13
H-Index
1
About
Claus Wittekindt is a leading head and neck surgeon whose research focuses on optimizing treatment strategies for oropharyngeal squamous cell carcinoma (OPSCC), with a particular emphasis on transoral surgery and organ-preserving therapies. His most notable contribution is the TopROC trial (2020), a landmark comparative effectiveness study that systematically evaluated transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for locoregionally advanced but transorally resectable OPSCC. This work addresses a critical clinical equipoise, providing evidence to guide treatment selection between surgical and non-surgical approaches. With 13 citations, the trial has already influenced clinical decision-making and sparked further investigation into de-escalation strategies and functional outcomes. Wittekindt’s research bridges surgical oncology and radiation oncology, helping to refine risk-adapted protocols that balance oncologic control with quality of life. His contributions are particularly impactful in the era of HPV-related OPSCC, where treatment de-intensification is a priority. For students and researchers, his work exemplifies how rigorous comparative trials can resolve longstanding debates in head and neck cancer management.
Research Focus
Key Achievements
Top Papers
- 1